Delisting risk
LFWD · NASDAQ · Medical - Devices

Lifeward

Powered exoskeletons and anti-gravity treadmills for mobility and rehabilitation.

$7.47
After-hours close+0.01 (+0.13%)
At close$7.46(+1.29%)

Breakdown13F · Form 4

Institutions 0.87%14.1K sharesInsiders 7.65%123.2K sharesOther 91.48%1.47M shares

Shares outstanding 1.61M · Float 1.56M · 96.7% free float

A split settled inside the quarter being compared, so quarter-on-quarter change is not shown.

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
Oramed Pharmaceuticals Inc. · 10 percent owner1.25M77.61%Form 4May 14, 2026
Avraham Gabay · director13.6K0.85%Form 4Aug 24, 2026
Moshe H. Rozenbaum · director11.5K0.71%Form 4Apr 13, 2026
William Mark Sigsbee · director11.5K0.71%Form 4Apr 13, 2026
Renaissance Technologies LLC11.4K0.71%13FMay 14, 2026

Institutions13F, as of Mar 31, 2026

8 holders · 14.1K shares

HolderShares% outstandingChg q/qFiled
Renaissance Technologies LLC11.4K0.71%May 14, 2026
UBS Group AG2.1K0.13%May 5, 2026
Morgan Stanley2080.01%May 15, 2026
Sbi Securities Co., Ltd.1960.01%Apr 28, 2026
Advisor Group Holdings, Inc.1070.01%May 15, 2026
National Bank of Canada /FI/110.00%May 15, 2026
Caitong International Asset Management Co., Ltd40.00%May 11, 2026
Group One Trading, L.P.20.00%May 13, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Oramed Pharmaceuticals Inc.49.90%1.53M13DMay 14, 2026

InsidersForm 4

InsiderRoleShares% outstandingFiled
Oramed Pharmaceuticals Inc.10 percent owner1.25M77.61%May 14, 2026
Avraham Gabaydirector13.6K0.85%Aug 24, 2026
Jeannine Lynchofficer: VP of Market Access & Strategy11.8K0.74%Dec 12, 2025
Moshe H. Rozenbaumdirector11.5K0.71%Apr 13, 2026
William Mark Sigsbeedirector11.5K0.71%Apr 13, 2026
Michael Swinforddirector9.3K0.57%Aug 7, 2025
Joseph E. Jr Turkdirector8.7K0.54%Aug 7, 2025
Lawrence J. Jasinskidirector, officer: Chief Executive Officer8.2K0.51%May 22, 2025
Nadav Kidrondirector7.7K0.48%Mar 27, 2026
Miriam Kidrondirector7.7K0.48%Mar 27, 2026

2 ten-percent owners hold 1.32M shares by Form 4 — the 13D/G table above shows those stakes, the figure above counts officers and directors only · 1 person has not refiled in the last 18 months (346 shares), so they are not in the figure above

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Sep 2, 2025
Jeannine Lynchofficer: VP of Market Access & Strategy
Sale1,591$0.640046,067

CongressHouse and Senate disclosures

Not reported.